International Scientific Advisory Board
Professor Rona Campbell 
Rona Campbell is Professor of Public Health Research, and leads the Centre for Public Health within Bristol Medical School's Department of Population Health Sciences at the University of Bristol. She is a National Institute for Health Research (NIHR) Senior Investigator and is the Bristol-based Director of the Development and Evaluation of Complex Interventions for Public Health Improvement group (DECIPHer) and the Bristol lead for the NIHR School for Public Health Research (SPHR) and Deputy Director of the national school.
Rona leads programmes of research concerned with multiple risk behaviour in adolescence and health promotion in schools. She is currently involved in a number of randomised controlled trials and systematic reviews all seeking evidence for the best ways to improve the health and well-being of children and young people.
Rona has a strong interest in methodological research, in particular, how to use qualitative methods alongside quantitative approaches, and how to make better use of social and behavioural theory in public health research.
Dr Sandro Galea 
Dr Galea is a physician and an epidemiologist. He is Dean and Professor at the Boston University School of Public Health. Prior to his appointment at Boston University, Dr Galea served as the Anna Cheskis Gelman and Murray Charles Gelman Professor and Chair of the Department of Epidemiology at the Columbia University Mailman School of Public Health where he launched several new educational initiatives and substantially increased its focus on six core areas: chronic, infectious, injury, lifecourse, psychiatric/neurological, and social epidemiology. He previously held academic and leadership positions at the University of Michigan and at the New York Academy of Medicine.
In his own scholarship, Dr Galea is centrally interested in the social production of health of urban populations, with a focus on the causes of brain disorders, particularly common mood-anxiety disorders and substance abuse. He has long had a particular interest in the consequences of mass trauma and conflict worldwide, including as a result of the September 11 attacks, Hurricane Katrina, conflicts in sub-Saharan Africa, and the American wars in Iraq and Afghanistan. This work has been principally funded by the National Institutes of Health, Centers for Disease Control and Prevention, and several foundations. He has published over 500 scientific journal articles, 50 chapters and commentaries, and 9 books and his research has been featured extensively in current periodicals and newspapers. His latest book, co-authored with Dr Katherine Keyes, is an epidemiology textbook, Epidemiology Matters: a new introduction to methodological foundations.
Dr Galea has a medical degree from the University of Toronto, and graduate degrees from Harvard University and Columbia University. He was named one of TIME magazine’s epidemiology innovators in 2006. He is past-president of the Society for Epidemiologic Research and an elected member of the American Epidemiological Society and of the Institute of Medicine of the National Academies of Science.
Dr Galea serves frequently on advisory groups to national and international organizations. He has formerly served as chair of the New York City Department of Health and Mental Hygiene’s Community Services Board and as member of its Health Board.
She has worked in most areas of Glasgow alongside communities to carry out change, including as part of a council Poverty Leadership Panel and then with North West Glasgow Voluntary Sector Network, working on a yearlong Participatory Budgeting Pilot, working with citizens to design and deliver a Participatory Budgeting process.
She worked for ten years in Homelessness in many different roles including training, managing advocacy and mentoring programmes, supporting hostel closure, and managing a long running multi- agency Tenancy Sustainment learning project. She currently works as the manager of North West Glasgow Voluntary Sector Network, supporting the work of third sector organisations and providing support, advocacy, training, representation, and latterly an IT recycling project. She is keen to ensure that the voices of the organisations are heard, and they share equal power with those statutory sectors they work with.
She is also an active volunteer, has been a literacy tutor and worked with asylum seekers and refugees teaching English, volunteered to run a library in her son's nursery, is current vice chair of her son's school Parent Council, and sits on the board of a local, urban nature reserve - Hamiltonhill Claypits Nature Reserve. She has won awards for her volunteering and charity work including Active Parent of the Year from Parent Network Scotland and Woman in Charity from BWC.
Her passion is the citizens of Glasgow and beyond; to serve them, to have the honour to work alongside them, and to fight for the rights of those are not yet able to fight for themselves.
Prof Dorairaj Prabhakaran 
Professor Dorairaj Prabhakaran, educated at Bangalore Medical College (MBBS), the All India Institute of Medical Sciences (MD: Internal Medicine and DM: Cardiology) and McMaster University Canada MSc: Health Research Methodology), is an eminent cardiologist, epidemiologist and academician of global repute. He moved beyond the conventional world of clinical cardiology to advance science in the prevention of heart diseases and diabetes in India so that his work could benefit millions of people in this country.
He established large population cohorts in India which have provided major insights in diverse domains, ranging from epidemiology, biomarkers, role of nutrition, on heart diseases and diabetes. Evaluation of task shifting and mobile‐phone based solutions for providing personalized patient management solutions, and Yoga-care in cardiac rehabilitation (both of which were selected for the prestigious late breaking presentation at the American Heart Association meeting in 2018), are two best exemplars of low cost, context specific solutions to enhance quality of therapeutic and preventive care for chronic diseases in India. A low cost worksite wellness program designed by his team with this philosophy was applauded by the 2008 World Economic Forum report, as one of the best worksite programs.
Prof Prabhakaran’s contribution to capacity building in chronic disease health research and training is exemplary. He was the founding Director of the Centre of Excellence in Cardia‐metabolic Risk Reduction in South Asia, one of the 11 centres worldwide supported under the Global Health Initiative of National Institutes of Health (NIH) of USA. This centre has now transformed into an international partnership namely ‘Centre for Control of Chronic Conditions (CCCC)’ between four world‐class institutions: the All India Institute of Medical Sciences, Emory University, LSHTM and PHFI. He is an exceptional mentor of doctoral, post‐doctoral and physician scientists nationally and internationally, many of whom have become leaders in heart disease research. Prof. Prabhakaran has by far, more than 500 publications in scientific journals such as the New England Journal of Medicine, The Lancet, Circulation, British Medical Journal, Nature, JAMA, etc. and has an H‐Index of 83. He was the lead editor of a major two volume text book of Cardiology which has been well received. He has been listed as the topmost researcher in Medicine in India terms of publications for the years 2009-2014 by Scopus and Department of Science & Technology, Government of India.
Prof Prabhakaran’s work has had large impact on science, health care and policy. Under his editorial leadership The World Bank published Cardiovascular Disease volume of the latest Disease Control Priorities Project. This volume estimates cost effectiveness of available interventions and provides a summary to policy makers across the world to prioritize their investments.
His exceptional contributions spanning Science, Medicine and Public Health has catapulted the field of Preventive Cardiology in India and in the developing world.
Professor Myrna Weissman
Dr Weissman is a Professor of Epidemiology in Psychiatry, College of Physicians and Surgeons and the Mailman School of Public Health at Columbia University and Chief of the Division of Epidemiology at New York State Psychiatric Institute (NYSPI). Until 1987, she was a Professor of Psychiatry and Epidemiology at Yale University School of Medicine and Director of the Depression Research Unit. She has been a Visiting Senior Scholar at the Institute of Medicine, National Academy of Sciences, Washington D.C. She received a Ph.D. in epidemiology from Yale University School of Medicine in 1974.
Her research is on understanding the rates and risks of mood and anxiety disorders using methods of epidemiology, genetics, neuroimaging, and the application of these findings to develop and test empirically based treatments and preventive intervention. Her current interest is in bringing psychiatric epidemiology closer to translational studies in the neurosciences and genetics. She directs a 3-generation study of families at high and low risk for depression who have been studied clinically for over 30 years and who are participating in electrophysiology and imaging studies. She has directed these multi-centered studies to determine the impact of maternal remission from depression on offspring. She is one of the PIs in a multi-centered study to find biomarkers of response to the treatment of depression and other disorders. Along with her late husband Gerald Klerman she developed Interpersonal Psychotherapy, an evidenced-based treatment for depression with over 100 clinical trials of efficacy. Studies using IPT have been carried out worldwide and a manual for group IPT is available through the World Health Organization.
Dr Weissman has been a consultant to many private and public agencies, and is a member of the National Academy of Medicine. She has been the author or a co-author of over 600 scientific articles and chapters, and 11 books. She has been the recipient of numerous grants from NIMH, NARSAD Senior Investigators Awards; grants from other private foundations and numerous awards for her research. She is on the editorial board of several journals including JAMA Psychiatry, Biological Psychiatry.
In April 2009, she was selected by the American College of Epidemiology as 1 of 10 epidemiologists in the United States who has had a major impact on public policy and public health. The summary of her work on depression appears in a special issue of the Annals of Epidemiology, Triumphs in Epidemiology. In January 2016 she was listed as one of the 100 highly cited authors in Google Scholars Citation.